Possible molecular target therapy with rapamycin in MDS.
Maeda Y, Yamaguchi T, Hijikata Y, Matsuoka T, Tanaka M, Morita Y, Hirase C, Takai S, Tatsumi Y, Matsuda M, Kanamaru A.
Maeda Y, et al. Among authors: hirase c.
Leuk Lymphoma. 2006 May;47(5):907-11. doi: 10.1080/10428190500467859.
Leuk Lymphoma. 2006.
PMID: 16753877